MedPath

Preanesthetic medication in pediatric patients: A comparison of midazolam, clonidine and dexmedetomidine

Phase 1
Conditions
Is there a difference in anxiety- and sedation-level, and in anesthesia induction compliance between the preanesthetics included in study, in pediatric patients? Can we prevent and reduce anxiety without causing negative cardiorespiratory effects by selected preanesthetic included in study, in TIVA in pediatric patients? Does the preanesthetic used in this study prevent and/or reduce pain, vomiting, shivering, events of emergence delirium and maladaptive behaviors, without prolonging recovery?
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2015-003676-70-SE
Lead Sponsor
orrbottens läns landsting
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Informed consent from both parents
Both genders
2-6 years of age
ASA I-II
Elective ENT-surgery
Weight: =30 kg
Language: Swedish

Are the trial subjects under 18? yes
Number of subjects for this age range: 300
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

ASA > II
Hypersensitive to study drug
Resent surgery
Failure of vital organs (heart, lung, liver, kidneys)
Central nervous system disorder or mental retardation
Psychotropic medical use

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath